Improving Efficacy

Dendrimers can improve efficacy of drugs by enabling a longer half-life, extended release and targetting of diseased tissue (in particular cancerous tissue). 


Docetaxel is a leading chemotherapy used to treat a range of solid tumours. Starpharma compared the performance of docetaxel to a DEPTM docetaxel formulation in a breast cancer model in mice. The results of the study showed that Starpharma’s DEPTM docetaxel formulation demonstrated a significant enhancement of anticancer activity when compared to docetaxel alone. 60% of the mice treated with Starpharma’s DEPTM docetaxel formulation had no evidence of tumours at 94 days whereas with docetaxel alone significant tumour regrowth was observed in all animals. 




Download  DEP Drug Delivery Summary ( pdf file, 1007kb) or Contact Us for further information.